{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T08:16:05Z","timestamp":1772180165651,"version":"3.50.1"},"reference-count":25,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,7,30]]},"DOI":"10.1536\/ihj.20-772","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T22:07:09Z","timestamp":1625522829000},"page":"742-751","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Aspirin Combined with Low-Dose P2Y12 Receptor Antagonists in East Asian Patients Undergoing PCI"],"prefix":"10.1536","volume":"62","author":[{"given":"Xiankang","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes Center of People's Liberation Army, Strategic Support Force Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiongyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Southwest Hospital, Third Military Medical University (Army Medical University)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Levine GN, Bates ER, Bittl JA, <i>et al<\/i>. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 2016; 152: 1243-75.","DOI":"10.1016\/j.jtcvs.2016.07.044"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wiviott SD, Braunwald E, McCabe CH, <i>et al<\/i>. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-15.","DOI":"10.1056\/NEJMoa0706482"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wallentin L, Becker RC, Budaj A, <i>et al<\/i>. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-57.","DOI":"10.1056\/NEJMoa0904327"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ib\u00e1nez B, James S, Agewall S, <i>et al<\/i>. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Rev Esp Cardiol (Engl Ed) 2017; 70: 1082.","DOI":"10.1016\/j.rec.2017.11.010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jeong YH.  &quot;East asian paradox&quot;: Challenge for the current antiplatelet strategy of &quot;one-guideline-fits-all races&quot; in acute coronary syndrome. Curr Cardiol Rep 2014; 16: 485.","DOI":"10.1007\/s11886-014-0485-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kohsaka S, Miyata H, Ueda I, <i>et al<\/i>. An international comparison of patients undergoing percutaneous coronary intervention: a collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan cardiovascular Database-Keio interhospital cardiovascular Studies (JCD-KiCS). Am Heart J 2015; 170: 1077-85.","DOI":"10.1016\/j.ahj.2015.09.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Knobloch K, Yoon U, Vogt PM. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 2011; 39: 91-2.","DOI":"10.1016\/j.jcms.2010.11.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang Y, Zhao HW, Wang CF, <i>et al<\/i>. Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east Asian patients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study. BMC Cardiovasc Disord 2020; 20: 109.","DOI":"10.1186\/s12872-019-01307-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saito S, Isshiki T, Kimura T, <i>et al<\/i>. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study. Circ J 2014; 78: 1684-92.","DOI":"10.1253\/circj.CJ-13-1482"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohkubo K, Fujimoto Y, Iwata Y, <i>et al<\/i>. Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart Vessels 2014; 29: 1-6.","DOI":"10.1007\/s00380-012-0318-6"},{"key":"11","unstructured":"11. Xu Y, Wang T, Fang W. A pilot study on efficacy and safety profile of a low clopidogrel maintenance dose following drug eluting stent implantation. Chin J Interv Cardiol 2009; 17: 255-8."},{"key":"12","unstructured":"12. Gao S, Wei Z, Sun X. The comparison of effectiveness and safety between the different doses of clopidogrel in the patients after percutaneous coronary intervention. J Jining Med Univ 2013; 36: 341-3."},{"key":"13","unstructured":"13. Zhao H, Luan B, Hou A, <i>et al<\/i>. Efficacy and safety of low-dose ticagrelor in antiplatelet therapy in patients with chronic total occlusion of coronary artery after PCI. Chin J Evid-Based Cardiovasc Med 2020; 20: 58-61."},{"key":"14","unstructured":"14. Zheng R, Xu Z, Chen X, <i>et al<\/i>. Effect and safety of different antiplatelet regimens on elder patients undergoing PCI after 6 months. Mod Med J 2020; 48: 56-60."},{"key":"15","unstructured":"15. Zhao Z, Zhang L, Liu M, <i>et al<\/i>. An individualized study on efficacy and safety of a low clopidogrel maintenance dose following drug eluting stent implantation. Chin J Front Med Sci 2013; 5: 81-5."},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Gurbel PA, Bliden KP, Butler K, <i>et al<\/i>. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation 2009; 120: 2577-85.","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Brandt JT, Payne CD, Wiviott SD, <i>et al<\/i>. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 2007; 153: 66.e9-16.","DOI":"10.1016\/j.ahj.2006.10.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Choi KN, Jin HY, Shin HC, <i>et al<\/i>. Comparison of the antiplatelet effects of once and twice daily low-dose ticagrelor and clopidogrel after percutaneous coronary intervention. Am J Cardiol 2017; 120: 201-6.","DOI":"10.1016\/j.amjcard.2017.04.010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jin HY, Yang TH, Choi KN, <i>et al<\/i>. Randomized comparison of the platelet inhibitory efficacy between low dose prasugrel and standard dose clopidogrel in patients who underwent percutaneous coronary intervention. Korean Circ J 2014; 44: 82-8.","DOI":"10.4070\/kcj.2014.44.2.82"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ozawa T, Suda M, Ikegami R, <i>et al<\/i>. Dual antiplatelet therapy guided by CYP2C19 polymorphisms after implantation of second-generation drug-eluting stents for management of acute coronary syndrome. Int Heart J 2018; 59: 21-6.","DOI":"10.1536\/ihj.17-005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Scott SA, Sangkuhl K, Stein CM, <i>et al<\/i>. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther 2013; 94: 317-23.","DOI":"10.1038\/clpt.2013.105"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mega JL, Close SL, Wiviott SD, <i>et al<\/i>. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009; 360: 354-62.","DOI":"10.1056\/NEJMoa0809171"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jeong YH, Abadilla KA, Tantry US, <i>et al<\/i>. Influence of CYP2C19*2 and *3 loss-of-function alleles on the pharmacodynamic effects of standard- and high-dose clopidogrel in East Asians undergoing percutaneous coronary intervention: the results of the ACCEL-DOUBLE-2N3 study. J Thromb Haemost 2013; 11: 1194-7.","DOI":"10.1111\/jth.12200"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Mega JL, Close SL, Wiviott SD, <i>et al<\/i>. Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 2009; 119: 2553-60.","DOI":"10.1161\/CIRCULATIONAHA.109.851949"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Wallentin L, James S, Storey RF, <i>et al<\/i>. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the Plato trial. Lancet 2010; 376: 1320-8.","DOI":"10.1016\/S0140-6736(10)61274-3"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/4\/62_20-772\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T03:47:49Z","timestamp":1627703269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/4\/62_20-772\/_article"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-772","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"article-number":"20-772"}}